RAPP
RAPP clinical trials: Rapport Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Rapport Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 6
- Trials linked
- 6
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
RAPP on the catalyst calendar · RAPP registry changes
- Primary completion Feb 3, 2028Sponsor estimatePhase 2NCT07219407A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset SeizuresRapport Therapeutics Inc. · Focal EpilepsyRecruitingRAPPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2029Sponsor estimatePhase 3NCT07594119Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal SeizuresRapport Therapeutics Inc. · Focal SeizureRecruitingRAPPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2029Sponsor estimatePhase 3NCT07563881Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1Rapport Therapeutics Inc. · Focal SeizureRecruitingRAPPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2027Sponsor estimatePhase 1NCT07923097Study Designed to Evaluate the Safety, Tolerability, and PK of RAP-219 Formulated as an Long Acting Injectable.Rapport Therapeutics Inc. · EpilepsyRecruitingRAPPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 5, 2026ActualPhase 2NCT07046494Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I DisorderRapport Therapeutics Inc. · Bipolar 1 DisorderCompletedRAPPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 26, 2025ActualPhase 2NCT06377930Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal EpilepsyRapport Therapeutics Inc. · Focal Onset SeizuresCompletedRAPPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 6 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner